Latest Biotech News

Pediatric research yields new insights into disease mechanisms and treatments. Automated EEG analysis offers early outcome predictions for newborns with hypoxic-ischemic encephalopathy treated...

The biotech sector experiences notable deal activity and regulatory changes. Supernus Pharmaceuticals announced a $795 million acquisition of Sage Therapeutics, integrating its postpartum...

Research highlights the multifaceted effects of climate and urbanization on health and ecosystems. Studies reveal rising nighttime temperatures increase health risks such as premature births and...

The 2025 BIO International Convention highlighted the critical need for sustained collaboration between government agencies and the biotech industry to enhance America's biodefense capabilities....

Sarepta Therapeutics has faced a second patient death from acute liver failure linked to its Duchenne muscular dystrophy gene therapy, Elevidys. Both fatalities involved non-ambulatory patients....

Recent expansions of artificial intelligence applications in biopharma encompass drug discovery, precision medicine, and diagnostic tools. Innovations include machine learning frameworks improving...

Supernus Pharmaceuticals is acquiring Sage Therapeutics for up to $795 million, securing rights to Sage's postpartum depression drug Zurzuvae. The acquisition follows Sage's decline from a $9...

Scientists at King's College London developed a cutting-edge nanoneedle patch featuring tens of millions of microscopic silicon-based needles. This technology is poised to revolutionize...

Imaging genomics, combining multi-modal imaging technologies with omics data, is evolving with the aid of AI and deep learning to decode complex disease mechanisms at molecular levels. This...

Recent studies shed light on epigenetic regulation mechanisms in persistent pulmonary hypertension of the newborn (PPHN) and male reproductive toxicity linked to PFAS exposure. Researchers...

Cutting-edge research spans multiple fronts including an algorithm, TACIT, that accelerates cell type classification in multiplexed imaging; multifunctional nanoparticles allowing bimodal...

Regulatory agencies continue to adjust resource allocations and policy frameworks impacting drug development timelines, oversight of lab-developed tests, and clinical trial acceleration, as...

Emerging research reveals environmental factors impacting human and ecosystem health, from PFAS-degrading bacteria discovered in Veneto soil to artificial light extending urban growing seasons...

Sarepta Therapeutics has suspended shipments of its Duchenne muscular dystrophy gene therapy, Elevidys, for non-ambulatory patients following a second fatal case of acute liver failure (ALF). Both...

Supernus Pharmaceuticals is acquiring Sage Therapeutics for up to $795 million, adding the FDA-approved postpartum depression treatment Zurzuvae to its portfolio. The acquisition follows a series...

BioNTech has finalized an all-stock acquisition of CureVac valued at approximately $1.25 billion, bringing the German mRNA vaccine competitor under its umbrella as a subsidiary. The merger...

Recent developments highlight the expanding role of AI and machine learning in accelerating drug discovery and diagnostic capabilities. University of Sheffield and AstraZeneca unveiled MapDiff, an...

Innovations in diagnostics and treatments are advancing rapidly. King's College London researchers developed a nanoneedle patch offering painless tissue molecular sampling, potentially replacing...

Significant progress has been made in understanding and managing neonatal and pulmonary conditions. A study elucidated cardiorespiratory improvements following transcatheter closure of patent...

Biotech innovation faces evolving regulatory and financing environments. FDA Commissioner Marty Makary is planning further agency consolidations aimed at operational efficiency amid staffing...